Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Products Imported As Supplements Contain Anticonvulsants, Cholesterol Drugs

This article was originally published in The Tan Sheet

Executive Summary

A July 15 import alert states that FDA and U.S. Customs officials can detain without physical examination certain imports from 20 foreign firms, including 14 from China.

Advertisement

Related Content

Adverse Event Contact, GMPs Send Foreign Supplement Firms To Import Alerts
Senators Push Park Doctrine Prosecution For Spiked Supplement ‘Criminal Endeavors’

Topics

Advertisement
UsernamePublicRestriction

Register

PS107858

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel